Hinge Health's (NYSE:HNGE - Get Free Report) quiet period will expire on Tuesday, July 1st. Hinge Health had issued 13,666,000 shares in its IPO on May 22nd. The total size of the offering was $437,312,000 based on an initial share price of $32.00. During Hinge Health's quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the company. Piper Sandler started coverage on Hinge Health in a research report on Monday, June 16th. They issued an "overweight" rating and a $41.00 price objective for the company. Morgan Stanley assumed coverage on Hinge Health in a research note on Monday, June 16th. They set an "overweight" rating and a $46.00 price objective on the stock. Needham & Company LLC assumed coverage on Hinge Health in a research note on Monday, June 16th. They issued a "buy" rating and a $47.00 price target on the stock. Stifel Nicolaus initiated coverage on Hinge Health in a research note on Monday, June 16th. They issued a "buy" rating and a $48.00 price target on the stock. Finally, Evercore ISI initiated coverage on Hinge Health in a research note on Monday, June 16th. They set an "outperform" rating and a $50.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat, Hinge Health currently has an average rating of "Moderate Buy" and an average price target of $46.00.
Read Our Latest Stock Analysis on HNGE
Hinge Health Trading Up 3.6%
NYSE HNGE opened at $43.60 on Tuesday. Hinge Health has a 1-year low of $33.42 and a 1-year high of $45.98.
Hinge Health Company Profile
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.